Evidence map›Paper›PMID 22590648›Full record

ArticlePloS one2012

Distinct RGK GTPases differentially use α1- and auxiliary β-binding-dependent mechanisms to inhibit CaV1.2/CaV2.2 channels.

Tingting Yang, Akil Puckerin, Henry M Colecraft

Abstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Oxidative Regulation of Vascular CaAntioxidants (Basel, Switzerland) · 2022
    Review
  9. Rad regulation of CaNature cardiovascular research · 2022
    Article
  10. Review
  11. Review
  12. Review
  13. Reconstitution of β-adrenergic regulation of CaProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  14. The life cycle of voltage-gated CaNeuronal signaling · 2021
    Review
  15. The βFrontiers in cardiovascular medicine · 2021
    Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Engineering selectivity into RGK GTPase inhibition of voltage-dependent calcium channels.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tingting YangDepartment of Physiology and Cellular Biophysics, Columbia University, College of Physicians and Surgeons, New York, New York, United States of America. ty2190@columbia.edu
Akil Puckerin
Henry M Colecraft

Funding

Molecular Determinants of L-type Calcium Channel GatingR01HL069911 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI COLECRAFT, HENRY M. · 2002 to 2011
$3.3M
RGK GTPases/Ca2+ Channel Cross TalkR01HL084332 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI COLECRAFT, HENRY M. · 2007 to 2010
$1.6M
NHLBI NIH HHS R01 HL069911NHLBI NIH HHS R01 HL084332
6 · The paper itself

Abstract

Ca(V)1/Ca(V)2 channels, comprised of pore-forming α(1) and auxiliary (β,α(2)δ) subunits, control diverse biological responses in excitable cells. Molecules blocking Ca(V)1/Ca(V)2 channel currents (I(Ca)) profoundly regulate physiology and have many therapeutic applications. Rad/Rem/Rem2/Gem GTPases (RGKs) strongly inhibit Ca(V)1/Ca(V)2 channels. Understanding how RGKs block I(Ca) is critical for insights into their physiological function, and may provide design principles for developing novel Ca(V)1/Ca(V)2 channel inhibitors. The RGK binding sites within Ca(V)1/Ca(V)2 channel complexes responsible for I(Ca) inhibition are ambiguous, and it is unclear whether there are mechanistic differences among distinct RGKs. All RGKs bind β subunits, but it is unknown if and how this interaction contributes to I(Ca) inhibition. We investigated the role of RGK/β interaction in Rem inhibition of recombinant Ca(V)1.2 channels, using a mutated β (β(2aTM)) selectively lacking RGK binding. Rem blocked β(2aTM)-reconstituted channels (74% inhibition) less potently than channels containing wild-type β(2a) (96% inhibition), suggesting the prevalence of both β-binding-dependent and independent modes of inhibition. Two mechanistic signatures of Rem inhibition of Ca(V)1.2 channels (decreased channel surface density and open probability), but not a third (reduced maximal gating charge), depended on Rem binding to β. We identified a novel Rem binding site in Ca(V)1.2 α(1C) N-terminus that mediated β-binding-independent inhibition. The Ca(V)2.2 α(1B) subunit lacks the Rem binding site in the N-terminus and displays a solely β-binding-dependent form of channel inhibition. Finally, we discovered an unexpected functional dichotomy amongst distinct RGKs- while Rem and Rad use both β-binding-dependent and independent mechanisms, Gem and Rem2 use only a β-binding-dependent method to inhibit Ca(V)1.2 channels. The results provide new mechanistic perspectives, and reveal unexpected variations in determinants, underlying inhibition of Ca(V)1.2/Ca(V)2.2 channels by distinct RGK GTPases.

Indexed as

Binding SitesCalcium Channels, L-TypeCalcium Channels, N-TypeHEK293 CellsHumansIon Channel GatingMonomeric GTP-Binding ProteinsProtein BindingCACNA1B protein, humanCalcium Channels, L-TypeCalcium Channels, N-TypeL-type calcium channel alpha(1C)Monomeric GTP-Binding Proteins

Identifiers

PMID22590648
PMCPMC3349659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.